Indeed, the interplay between dyslipidemia and various metabolic disturbances is multifaceted, involving systemic inflammation, oxidative stress and insulin resistance, which collectively contribute to increased cardiometabolic risk [34]. Here, INS is linked to metabolic syndrome.